Aptevo Therapeutics Inc. (APVO)
NASDAQ·Healthcare·Biotechnology
$4.96
+0.81%
Mkt Cap $10.82M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 20, 2026 | — | — | — | -$8.09 | $1684.47 | +20921.63% | — | — |
| Q4 2025 Nov 6, 2025 | — | — | — | -$37.59 | -$40.11 | -6.70% | — | — |
| Q3 2025 Aug 11, 2025 | — | — | — | -$0.45 | -$151.08 | -33473.33% | — | — |
| Q2 2025 May 15, 2025 | — | — | — | -$1514.39 | -$1579.14 | -4.28% | — | — |
| Q1 2025 Mar 4, 2025 | — | — | — | -$7.75 | -$82.37 | -962.84% | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$7428.84 | -$6255.86 | +15.79% | — | — |
| Q3 2024 Aug 8, 2024 | — | — | — | -$25153.80 | -$21765.20 | +13.47% | — | — |
| Q2 2024 May 8, 2024 | — | — | — | -$183766.00 | -$129679.00 | +29.43% | — | — |
| Q1 2024 Mar 5, 2024 | — | — | — | -$18.04 | -$6.16 | +65.85% | — | — |
| Q4 2023 Nov 14, 2023 | — | — | — | -$413383.00 | -$287072.00 | +30.56% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$643040.00 | -$706196.00 | -9.82% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$683230.00 | $149277.00 | +121.85% | — | — |
| Q1 2023 Mar 30, 2023 | — | — | — | -$1.53 | -$0.95 | +37.91% | — | — |
| Q4 2022 Nov 10, 2022 | — | — | — | -$941595.00 | -$878439.00 | +6.71% | — | — |
| Q3 2022 Aug 11, 2022 | $3.45M | — | — | -$763610.00 | -$1067910.00 | -39.85% | — | — |
| Q2 2022 May 12, 2022 | $3.75M | $3.11M | -16.96% | -$660265.00 | -$912888.00 | -38.26% | — | — |
| Q1 2022 Mar 24, 2022 | $3.40M | $3.67M | +7.79% | -$1.29 | -$1.27 | +1.55% | — | — |
| Q4 2021 Nov 12, 2021 | $3.16M | $3.10M | -1.99% | -$849732.00 | -$832508.00 | +2.03% | — | — |
| Q3 2021 Aug 12, 2021 | $900.00K | $3.11M | +245.56% | -$1119580.00 | -$1021970.00 | +8.72% | — | — |
| Q2 2021 May 11, 2021 | $6.47M | $2.42M | -62.59% | -$930112.00 | -$999009.00 | -7.41% | — | — |